Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 2 |
2024 | 2 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Discovery of a Novel Bloom's Syndrome Protein (BLM) Inhibitor Suppressing Growth and Metastasis of Prostate Cancer.
Int J Mol Sci. 2022 Nov 26;23(23):14798. doi: 10.3390/ijms232314798.
Int J Mol Sci. 2022.
PMID: 36499126
Free PMC article.
ML216-Induced BLM Helicase Inhibition Sensitizes PCa Cells to the DNA-Crosslinking Agent Cisplatin.
Ma XY, Zhao JF, Ruan Y, Zhang WM, Zhang LQ, Cai ZD, Xu HQ.
Ma XY, et al.
Molecules. 2022 Dec 12;27(24):8790. doi: 10.3390/molecules27248790.
Molecules. 2022.
PMID: 36557923
Free PMC article.
Item in Clipboard
Circ_0001671 regulates prostate cancer progression through miR-27b-3p/BLM axis.
Yang L, Ruan Y, Chen B, Zhu Y, Xu H.
Yang L, et al.
Sci Rep. 2024 May 28;14(1):12181. doi: 10.1038/s41598-024-63068-x.
Sci Rep. 2024.
PMID: 38806577
Free PMC article.
Item in Clipboard
HIST3H2A promotes the progression of prostate cancer through inhibiting cell necroptosis.
Yang L, Ruan Y, Xu H.
Yang L, et al.
BMC Cancer. 2024 Apr 29;24(1):544. doi: 10.1186/s12885-024-12308-4.
BMC Cancer. 2024.
PMID: 38684944
Free PMC article.
Item in Clipboard
Cite
Cite